Study of the Efficacy of ESTRATEST® H.S. Tablets in Relieving Menopausal Symptoms in Estrogenized Postmenopausal Women
Public ClinicalTrials.gov record NCT00141570. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Double-Blind Study to Determine the Efficacy of ESTRATEST® H.S. Tablets in Relieving Menopausal Symptoms in Estrogenized Postmenopausal Women
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To determine whether treatment with ESTRATEST® H.S. Tablets is superior to treatment with esterified estrogens tablets
Study identification
- NCT ID
- NCT00141570
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 350 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 30 Years to 65 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2004 (Type not available)
- Primary completion
- Jun 2007 (Actual)
- Completion
- Jun 2007 (Actual)
- Last update posted
- Jan 16, 2015
2004 – 2007
United States locations
- U.S. sites
- 77
- U.S. states
- 29
- U.S. cities
- 77
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 66 | Huntsville | Alabama | — | — |
| Site 57 | Mobile | Alabama | — | — |
| Site 46 | Montgomery | Alabama | — | — |
| Site 29 | Phoenix | Arizona | — | — |
| Site 15 | Tucson | Arizona | — | — |
| Site 3 | Jonesboro | Arkansas | — | — |
| Site 22 | Little Rock | Arkansas | — | — |
| Site 68 | Carmichael | California | — | — |
| Site 55 | Encinitas | California | — | — |
| Site 6 | San Diego | California | — | — |
| Site 45 | Santa Rosa | California | — | — |
| Site 25 | Walnut Creek | California | — | — |
| Site 26 | Denver | Colorado | — | — |
| Site 1 | Groton | Connecticut | — | — |
| Site 54 | Hartford | Connecticut | — | — |
| Site 30 | Trumbull | Connecticut | — | — |
| Site 34 | Waterbury | Connecticut | — | — |
| Site 10 | Aventura | Florida | — | — |
| Site 73 | Fort Myers | Florida | — | — |
| Site 51 | Leesburg | Florida | — | — |
| Site 49 | Melbourne | Florida | — | — |
| Site 64 | New Port Richey | Florida | — | — |
| Site 61 | Ocala | Florida | — | — |
| Site 27 | Palm Springs | Florida | — | — |
| Site 11 | Pinellas Park | Florida | — | — |
| Site 75 | Sarasota | Florida | — | — |
| Site 69 | St. Petersburg | Florida | — | — |
| Site 70 | Venice | Florida | — | — |
| Site 17 | West Palm Beach | Florida | — | — |
| Site 50 | Alpharetta | Georgia | — | — |
| Site 5 | Atlanta | Georgia | — | — |
| Site 44 | Decatur | Georgia | — | — |
| Site 77 | Douglasville | Georgia | — | — |
| Site 9 | Riverdale | Georgia | — | — |
| Site 7 | Savannah | Georgia | — | — |
| Site 47 | Boise | Idaho | — | — |
| Site 24 | Champaign | Illinois | — | — |
| Site 20 | Chicago | Illinois | — | — |
| Site 76 | Peoria | Illinois | — | — |
| Site 58 | Evansville | Indiana | — | — |
| Site 39 | Wichita | Kansas | — | — |
| Site 59 | Baton Rouge | Louisiana | — | — |
| Site 52 | New Orleans | Louisiana | — | — |
| Site 53 | Ann Arbor | Michigan | — | — |
| Site 63 | Kansas City | Missouri | — | — |
| Site 32 | Richmond Heights | Missouri | — | — |
| Site 36 | St Louis | Missouri | — | — |
| Site 72 | Billings | Montana | — | — |
| Site 21 | Lincoln | Nebraska | — | — |
| Site 37 | Reno | Nevada | — | — |
| Site 65 | Cary | North Carolina | — | — |
| Site 13 | New Bern | North Carolina | — | — |
| Site 16 | Winston-Salem | North Carolina | — | — |
| Site 60 | Columbus | Ohio | — | — |
| Site 67 | Oklahoma City | Oklahoma | — | — |
| Site 40 | Tulsa | Oklahoma | — | — |
| Site 62 | Eugene | Oregon | — | — |
| Site 41 | Medford | Oregon | — | — |
| Site 33 | Portland | Oregon | — | — |
| Site 18 | Erie | Pennsylvania | — | — |
| Site 19 | Philadelphia | Pennsylvania | — | — |
| Site 23 | Pottstown | Pennsylvania | — | — |
| Site 31 | Anderson | South Carolina | — | — |
| Site 35 | Greer | South Carolina | — | — |
| Site 4 | Chattanooga | Tennessee | — | — |
| Site 74 | Conroe | Texas | — | — |
| Site 8 | Corpus Christi | Texas | — | — |
| Site 71 | Dallas | Texas | — | — |
| Site 42 | Houston | Texas | — | — |
| Site 14 | San Antonio | Texas | — | — |
| Site 38 | Salt Lake City | Utah | — | — |
| Site 28 | Norfolk | Virginia | — | — |
| Site 12 | Richmond | Virginia | — | — |
| Site 56 | Renton | Washington | — | — |
| Site 2 | Seattle | Washington | — | — |
| Site 48 | Spokane | Washington | — | — |
| Site 43 | Tacoma | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00141570, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 16, 2015 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00141570 live on ClinicalTrials.gov.